Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic ...

Viatris and Opus Genetics report MR-141 met efficacy and safety goals in Phase 3 VEGA-3 trial for presbyopia, with strong patient-reported benefits.

Shares of Viatris Inc. VTRS rallied 2.80% to $9.18 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.91% ...

Results from the Phase III VEGA-3 trial (NCT06542497) show that significantly more patients treated with Viatris and Opus Genetics’ MR-141 (phentolamine ophthalmic solution 0.75%) for presbyopia ...

(RTTNews) - Viatris Inc. (VTRS), Thursday announced positive top-line results from VEGA-3, evaluating MR-141 in patients with presbyopia, the progressive loss of the ability to focus on close objects.

San Diego-based Jack in the Box Inc. this week adopted a “poison pill” to fend off any potential takeover attempt by San Antonio investor Sardar Biglari. Shown is its mascot, Jack Box.

PITTSBURGH, June 26, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from VEGA-3, the second pivotal Phase 3 trial ...

Viatris performance has remained lackluster over the longer term as well. VTRS stock has plummeted 28.9% on a YTD basis and 15.5% over the past 52 weeks, notably underperforming SPX’s 2.4% ...

Jack in the Box (JACK) said on Wednesday it has adopted a ‘poison pill’ plan effective immediately after activist investor Sardar Biglari’s hedge fund amassed 9.9% of the fast-food chain’s ...

Medicare drug plans usually cover the pill form of semaglutide for type 2 diabetes. Learn more about coverage and costs.

A Maryland man was sentenced to 18 years in prison for prescribing narcotics in exchange for cash from his medical clinic in Northwest Washington, D.C.